Skip to content
value.today
AngioDynamics, Inc. logo

AngioDynamics, Inc.

ANGO
$512 Mmarket cap on Oct 27, 2026+65.6% since Jan 2024
Compare
World rank
#12,451
Revenue
$320 M
For year ending May-2026
Net income
$-37 M
-11.5% margin
SEC filing
Employees
800
As on 2021
value.today research

AngioDynamics, Inc. in brief

AngioDynamics, Inc. is a listed company in the Medical Instruments industry, based in Latham, New York, USA. It was founded in 1988. Its market value was $512 M on 27 October 2026, which makes it the 12,451st largest listed company in the world and the 2,514th largest in the USA on this site. In the year to May 2026 it had sales of $320 M and a net loss of $37 M. It employs about 800 people and Eric Honroth is its chief executive. Its largest product and service lines by sales in 2026 were Med Device (53%) and Med Tech (47%). By market, the largest shares of its 2026 sales came from USA (86%). Its shares trade under the symbol ANGO (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About AngioDynamics, Inc.

AngioDynamics is a Global provider of Industry Medical Devices company used around the world for the treatment of cancer and peripheral vascular disease. The headquarters is in USA.

Angiodynamics company annual revenue was 338 million USD and annual net loss was -52 million USD as on May-2022.

AngioDynamics, Inc. timeline

4 events, 1988–2022
  1. 1988
  2. 🏁
    · approximate
    Founded
  3. 2004
  4. 🔔
    · approximate
    Initial public offering on Nasdaq
  5. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  6. 2022
  7. 💰
    Record revenue of $339 million
    FY2022, the highest of the 8 years on record.

Events of AngioDynamics, Inc. from the company record, SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$245 M$489 M$734 M$978 M2020202120222023202420252026

World rank over time

▼ down 2,414 places since 2020
2020-01-01: #10065#10,06520202021-01-01: #10701#10,70120212022-01-07: #9928#9,92820222022-12-25: #12175#12,17520222023-07-30: #15145#15,14520232024-01-05: #15577#15,57720242026-03-08: #7369#7,36920262026-08-01: #11185#11,18520262026-10-27: #12479#12,4792026

Rank in USA: #2,336 (Jan 2020) · #2,680 (Jan 2021) · #2,634 (Jan 2022) · #2,571 (Dec 2022) · #3,073 (Jul 2023) · #2,896 (Jan 2024) · #1,298 (Mar 2026) · #2,361 (Aug 2026) · #2,517 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
1.6×
Price / book
3.0×
Free cash flow yield
0.1%
Net margin (TTM)
-10.1%
Operating margin
-12.5%
Return on equity
-19.3%
Liabilities / assets
36.1%
Net debt
$-76M
Revenue growth
+9.5%
R&D / revenue
9.2%
Revenue per employee
$400 K
Profit per employee
$-46 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending May 2019: revenue $271M, net income $61M$271MFY19Fiscal year ending May 2020: revenue $264M, net income $-167M$264MFY20Fiscal year ending May 2021: revenue $291M, net income $-32M$291MFY21Fiscal year ending May 2022: revenue $316M, net income $-27M$316MFY22Fiscal year ending May 2023: revenue $339M, net income $-52M$339MFY23Fiscal year ending May 2024: revenue $304M, net income $-184M$304MFY24Fiscal year ending May 2025: revenue $293M, net income $-34M$293MFY25Fiscal year ending May 2026: revenue $320M, net income $-37M$320MFY26
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
May 2026$320M+9.5%$-40M$-37M-11.5%
May 2025$293M-3.8%$-40M$-34M-11.6%
May 2024$304M-10.3%$-192M$-184M-60.7%
May 2023$339M+7.1%$-51M$-52M-15.5%
May 2022$316M+8.7%$-28M$-27M-8.4%
May 2021$291M+10.2%$-35M$-32M-10.8%
May 2020$264M-2.4%$-167M$-167M-63.1%
May 2019$271M—$-9M$61M22.7%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
May 2026$3M$3M$1M$-0.88—
May 2025$-10M$4M$-15M$-0.83—
May 2024$-28M$3M$-31M$-4.59—
May 2023$0M$4M$-4M$-1.33—
May 2022$-7M$4M$-11M$-0.68—
May 2021$24M$5M$19M$-0.82—
May 2020$-15M$7M$-22M$-4.39—
May 2019$37M$3M$34M$1.64—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$325M
Net income, trailing 12 months
$-33M
RevenueNet income
Three months to Nov 2024: revenue $73M, net income $-11M$73MNov ’24Three months to Feb 2025: revenue $72M, net income $-4M$72MFeb ’25Three months to May 2025 (from the annual report): revenue $80M, net income $-6M$80MMay ’25Three months to Aug 2025: revenue $76M, net income $-11M$76MAug ’25Three months to Nov 2025: revenue $79M, net income $-6M$79MNov ’25Three months to Feb 2026: revenue $78M, net income $-8M$78MFeb ’26Three months to May 2026 (from the annual report): revenue $87M, net income $-11M$87MMay ’26Three months to Aug 2026: revenue $81M, net income $-7M$81MAug ’26

Latest quarter to Aug 2026: revenue $81M (+6.9% on a year earlier), net income $-7M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Aug 2026.

SEC filings

Official filings of AngioDynamics, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$320 M
Operating income
$-40 M
Net income
$-37 M

For year ending May-2026 · source: SEC filing

Balance sheet

Total assets
$267 M
Total liabilities
$96 M
Total equity
$171 M

As of May-2026

Top 100 institutional investors in AngioDynamics, Inc.#

As of Sep 30, 2026
171 institutions held 37.2 M shares (about 88.4% of the shares outstanding) on Sep 30, 2026. The ten largest hold 43.4%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in AngioDynamics, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1BlackRock, Inc.4,048,928+245,696 (+6.46%)9.63%$62 MNov 13, 2026
2Systematic Financial Management LP2,604,656-35,558 (-1.35%)6.19%$40 MNov 16, 2026
3Royce & Associates LP1,921,526-48,309 (-2.45%)4.57%$30 MNov 9, 2026
4Broadfin Holdings LLC1,758,949-59,584 (-3.28%)4.18%$27 MNov 16, 2026
5Vanguard Capital Management LLC1,712,073+17,357 (+1.02%)4.07%$26 MNov 13, 2026
6Armistice Capital, LLC1,536,000-662,000 (-30.12%)3.65%$24 MNov 16, 2026
7Weber Capital Management LLC /adv1,349,902-6,700 (-0.49%)3.21%$21 MOct 19, 2026
8Two Sigma Investments, LP1,276,984+970,724 (+316.96%)3.04%$20 MNov 16, 2026
9Arrowstreet Capital, Limited Partnership1,031,130+338,596 (+48.89%)2.45%$16 MNov 13, 2026
10Geode Capital Management, LLC1,014,694-5,964 (-0.58%)2.41%$16 MNov 6, 2026
11State Street Corp990,160+31,993 (+3.34%)2.35%$15 MNov 12, 2026
12Point72 Asset Management, L.P.964,953-2,097,564 (-68.49%)2.29%$15 MNov 16, 2026
13Dimensional Fund Advisors LP949,285-20,212 (-2.08%)2.26%$15 MNov 4, 2026
14Segall Bryant & Hamill, LLC897,065-29,646 (-3.20%)2.13%$14 MNov 16, 2026
15Nuveen, LLC884,564-314,794 (-26.25%)2.10%$14 MNov 10, 2026
16Pier Capital, LLC795,961-10,717 (-1.33%)1.89%$12 MNov 13, 2026
17Goldman Sachs Group Inc707,338+324,421 (+84.72%)1.68%$11 MNov 16, 2026
18AQR Capital Management LLC679,522+90,365 (+15.34%)1.62%$10 MNov 16, 2026
19Acadian Asset Management LLC670,159+181,898 (+37.25%)1.59%$10 MNov 9, 2026
20Renaissance Technologies LLC620,383-113,500 (-15.47%)1.48%$10 MNov 12, 2026
21Marshall Wace, LLP605,234+184,856 (+43.97%)1.44%$9 MNov 13, 2026
22Jacobs Levy Equity Management, Inc591,402+372,178 (+169.77%)1.41%$9 MNov 16, 2026
23Millennium Management LLC522,226-260,899 (-33.32%)1.24%$8 MNov 16, 2026
24Divisadero Street Capital Management, LP500,130New1.19%$8 MNov 16, 2026
25Vanguard Portfolio Management LLC445,949+5,105 (+1.16%)1.06%$7 MNov 13, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in AngioDynamics, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Morgan Stanley395,247+136,933 (+53.01%)0.94%$6 MNov 13, 2026
27Charles Schwab Investment Management Inc376,341+2,312 (+0.62%)0.89%$6 MNov 16, 2026
28Panagora Asset Management Inc364,872+106,303 (+41.11%)0.87%$6 MNov 12, 2026
29First Eagle Investment Management, LLC354,435-198,435 (-35.89%)0.84%$5 MNov 10, 2026
30Northern Trust Corp317,328-12,399 (-3.76%)0.75%$5 MNov 16, 2026
31Bastion Asset Management Inc.304,437-618,833 (-67.03%)0.72%$5 MNov 5, 2026
32Jpmorgan Chase & Co288,919+68,144 (+30.87%)0.69%$4 MNov 12, 2026
33Orion Porfolio Solutions, LLC263,710+77,866 (+41.90%)0.63%$4 MNov 12, 2026
34Vanguard Fiduciary Trust Co256,474-20,441 (-7.38%)0.61%$4 MNov 13, 2026
35Manatuck Hill Partners, LLC218,200-58,300 (-21.08%)0.52%$3 MNov 16, 2026
36SEI Investments Co196,165+78,896 (+67.28%)0.47%$3 MNov 10, 2026
37Kennedy Capital Management LLC188,836-4,090 (-2.12%)0.45%$3 MNov 13, 2026
38Invesco Ltd.185,994+88,150 (+90.09%)0.44%$3 MNov 12, 2026
39D. E. Shaw & Co., Inc.185,280New0.44%$3 MNov 16, 2026
40Bank Of America Corp /de/174,167-170,976 (-49.54%)0.41%$3 MNov 16, 2026
41UBS Group AG173,085+88,898 (+105.60%)0.41%$3 MNov 10, 2026
42Ameriprise Financial Inc163,378+63,976 (+64.36%)0.39%$3 MNov 16, 2026
43White Pine Capital LLC145,476+1,012 (+0.70%)0.35%$2 MNov 9, 2026
44Bank of New York Mellon Corp124,844+394 (+0.32%)0.30%$2 MNov 5, 2026
45Y-Intercept (Hong Kong) Ltd124,596+78,328 (+169.29%)0.30%$2 MOct 16, 2026
46FMR LLC124,458+19,942 (+19.08%)0.30%$2 MNov 10, 2026
47Paradigm Capital Management Inc/ny119,400-551,800 (-82.21%)0.28%$2 MNov 13, 2026
48Moore Capital Management, LP118,466-64,633 (-35.30%)0.28%$2 MNov 16, 2026
49Walleye Capital LLC114,525New0.27%$2 MNov 13, 2026
50Globeflex Capital L P104,1550 (0.00%)0.25%$2 MNov 16, 2026
51American Century Companies Inc98,338-200 (-0.20%)0.23%$2 MNov 12, 2026
52Franklin Templeton Inc92,677+68,474 (+282.92%)0.22%$1 MNov 12, 2026
53Natixis92,500New0.22%$1 MNov 6, 2026
54Trexquant Investment LP90,148+57,945 (+179.94%)0.21%$1 MNov 16, 2026
55Qube Research & Technologies Ltd89,389New0.21%$1 MNov 13, 2026
56Informed Momentum Co LLC87,098New0.21%$1 MNov 16, 2026
57Russell Investments Group, Ltd.75,085+4,895 (+6.97%)0.18%$1 MNov 6, 2026
58Royal Bank Of Canada72,911+537 (+0.74%)0.17%$1 MNov 16, 2026
59Quantinno Capital Management LP70,880+8,170 (+13.03%)0.17%$1 MNov 13, 2026
60Connor, Clark & Lunn Investment Management Ltd.70,717-50,556 (-41.69%)0.17%$1 MNov 10, 2026
61Citadel Advisors LLC67,392+54,908 (+439.83%)0.16%$1 MNov 16, 2026
62Mitsubishi UFJ Asset Management Co., Ltd.66,387+2,658 (+4.17%)0.16%$1 MNov 5, 2026
63Price T Rowe Associates Inc /MD/64,0980 (0.00%)0.15%$1 MNov 16, 2026
64Strs Ohio62,900+12,100 (+23.82%)0.15%$1 MOct 30, 2026
65Occudo Quantitative Strategies LP62,824New0.15%$1 MNov 16, 2026
66ExodusPoint Capital Management, LP62,767+31,493 (+100.70%)0.15%$1 MNov 16, 2026
67XTX Topco Ltd61,857+20,827 (+50.76%)0.15%$1 MNov 16, 2026
68Jane Street Group, LLC60,847New0.14%$1 MNov 12, 2026
69Envestnet Asset Management Inc54,313-741 (-1.35%)0.13%$1 MNov 16, 2026
70Prudential Financial Inc53,323+41,837 (+364.24%)0.13%$1 MNov 16, 2026
71HSBC Holdings PLC52,133+24,607 (+89.40%)0.12%$1 MNov 16, 2026
72Atria Investments, Inc48,344+3,136 (+6.94%)0.12%$1 MOct 15, 2026
73Moody National Bank Trust Division47,9270 (0.00%)0.11%$1 MOct 6, 2026
74Rhumbline Advisers47,776-1,933 (-3.89%)0.11%$1 MNov 10, 2026
75Squarepoint Ops LLC45,320+7,694 (+20.45%)0.11%$1 MNov 9, 2026
76Gallagher Fiduciary Advisors, LLC45,113-135 (-0.30%)0.11%$1 MNov 16, 2026
77Boothbay Fund Management, LLC45,019New0.11%$1 MNov 16, 2026
78Barclays PLC42,932+10,473 (+32.27%)0.10%$1 MNov 6, 2026
79StoneX Group Inc.41,339-2,222 (-5.10%)0.10%$1 MNov 3, 2026
80Alliancebernstein L.P.40,5670 (0.00%)0.10%$1 MNov 16, 2026
81Susquehanna International Group, LLP33,432+22,785 (+214.00%)0.08%$1 MNov 16, 2026
82Canada Pension Plan Investment Board32,9000 (0.00%)0.08%$1 MNov 16, 2026
83Mariner, LLC32,692+5,966 (+22.32%)0.08%$1 MNov 12, 2026
84Vanguard Global Advisers, LLC31,933+14,515 (+83.33%)0.08%$0 MNov 13, 2026
85Deutsche Bank AG\31,930-4,606 (-12.61%)0.08%$0 MNov 6, 2026
86Ieq Capital, LLC31,746+4,678 (+17.28%)0.08%$0 MNov 10, 2026
87Susquehanna Portfolio Strategies, LLC29,944New0.07%$0 MNov 16, 2026
88Mercer Global Advisors Inc /adv28,421+6,327 (+28.64%)0.07%$0 MNov 16, 2026
89Assenagon Asset Management S.A.27,727-27,727 (-50.00%)0.07%$0 MOct 15, 2026
90Cerity Partners LLC24,242+5,778 (+31.29%)0.06%$0 MNov 13, 2026
91Great Lakes Advisors, LLC22,382New0.05%$0 MNov 6, 2026
92MetLife Investment Management, LLC21,4880 (0.00%)0.05%$0 MNov 16, 2026
93Engineers Gate Manager LP21,386New0.05%$0 MNov 16, 2026
94Wealth Effects LLC20,750+3,400 (+19.60%)0.05%$0 MOct 23, 2026
95Fox Run Management, L.L.C.20,702-11,787 (-36.28%)0.05%$0 MNov 12, 2026
96Aquatic Capital Management LLC20,563-7,498 (-26.72%)0.05%$0 MNov 16, 2026
97Martingale Asset Management L P19,741New0.05%$0 MNov 12, 2026
98HRT Financial LP18,589New0.04%$0 MNov 13, 2026
99MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.17,770+632 (+3.69%)0.04%$0 MNov 16, 2026
100Public Employees Retirement System Of Ohio17,670+12,720 (+256.97%)0.04%$0 MNov 16, 2026

All 171 institutional investors, with who bought and sold →

Mutual funds holding AngioDynamics, Inc.#

158 funds in 2 countries hold shares worth $148 M (about 26.7% of the company). Since their previous reports 66 added shares and 43 sold, buying $4 M net. By country: USA 157 ($144 M), Sweden 1 ($4 M).
Mutual funds holding AngioDynamics, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.1.17 M$15 M2.8%<0.01%−3.1%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors973,144$13 M2.3%0.02%+5.7%Jun 30, 2026
🇺🇸 Royce Small-Cap Opportunity FundRoyce & Associates, LP707,398$9 M1.7%0.65%+11%Jun 30, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC626,469$8 M1.5%<0.01%−16%Jun 30, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.484,796$6 M1.2%<0.01%+2.6%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC406,661$6 M0.97%0.02%+9.6%Jul 31, 2026
🇺🇸 Nuveen Quant Small Cap Equity FundTeachers Advisors, LLC382,490$6 M0.91%0.14%−1.9%Jul 31, 2026
🇺🇸 First Eagle Small Cap Opportunity FundFirst Eagle Investment Management, LLC310,729$5 M0.74%0.16%+30%Jul 31, 2026
🇸🇪 SEB Nordamerikafond SmåbolagSEB Funds AB310,537$4 M0.74%1.4%+6.2%Jun 30, 2026
🇺🇸 Royce Micro-Cap Trust, Inc.Royce & Associates, LP283,939$4 M0.68%0.41%+60%Jun 30, 2026
🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors261,136$3 M0.62%0.02%+4.2%Jun 30, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP183,958$3 M0.44%0.01%no changeJul 31, 2026
🇺🇸 SBH Small Cap Value FundSEGALL BRYANT AND HAMILL LLC205,492$3 M0.49%0.60%no changeJun 30, 2026
🇺🇸 BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC224,372$3 M0.53%0.05%−1.3%May 29, 2026
🇺🇸 Paradigm Micro-Cap FundPARADIGM FUNDS ADVISOR LLC197,900$3 M0.47%1.4%−18%Jun 30, 2026
🇺🇸 iShares U.S. Medical Devices ETFBlackRock Fund Advisors193,491$3 M0.46%0.08%+9.2%Jun 30, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC214,612$2 M0.51%<0.01%−0.9%May 31, 2026
🇺🇸 Schwab U.S. Small-Cap ETFCharles Schwab Investment Management, Inc.203,599$2 M0.48%0.01%+3.4%May 31, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.192,158$2 M0.46%0.01%−1.4%May 31, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP143,620$2 M0.34%0.03%no changeJul 31, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP137,468$2 M0.33%0.01%no changeJul 31, 2026
🇺🇸 Royce Micro-Cap FundRoyce & Associates, LP140,402$2 M0.33%0.43%+68%Jun 30, 2026
🇺🇸 JPMorgan Small Cap Value FundJ.P. Morgan Investment Management Inc.130,994$2 M0.31%0.13%newJun 30, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP110,473$2 M0.26%<0.01%no changeJul 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors125,123$2 M0.30%0.11%+33%Jun 30, 2026
🇺🇸 Adara Smaller Companies FundRBB Fund, Inc.141,441$2 M0.34%0.20%+2.5%May 31, 2026
🇺🇸 Transamerica Small/Mid Cap ValueTransamerica Asset Management, Inc.104,350$2 M0.25%0.24%−9.3%Jul 31, 2026
🇺🇸 Vanguard Health Care Index FundThe Vanguard Group, Inc.124,182$1 M0.30%<0.01%+1.0%May 31, 2026
🇺🇸 Variable Portfolio - Partners Small Cap Value FundColumbia Management Investment Advisers, LLC103,495$1 M0.25%0.30%no changeJun 30, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.90,400$1 M0.21%0.02%+9.8%Jul 31, 2026
🇺🇸 Fidelity Enhanced Small Cap Core ETFFidelity Management & Research Company LLC97,802$1 M0.23%0.02%+11%Jun 30, 2026
🇺🇸 U.S. Core Equity 2 PortfolioDimensional Fund Advisors LP85,678$1 M0.20%<0.01%no changeJul 31, 2026
🇺🇸 Transamerica Small/Mid Cap Value VPTransamerica Asset Management, Inc.92,250$1 M0.22%0.21%−7.8%Jun 30, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors83,883$1 M0.20%<0.01%+17%Jun 30, 2026
🇺🇸 iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors83,274$1 M0.20%<0.01%+2.3%Jun 30, 2026
🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust90,394$1 M0.21%0.04%−0.1%May 31, 2026
🇺🇸 Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC68,308$1 M0.16%0.04%−9.3%Jul 31, 2026
🇺🇸 Goldman Sachs Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P.62,748$1 M0.15%0.09%newJul 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC70,651$1 M0.17%0.02%+15%Jun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC75,964$1 M0.18%<0.01%no changeMay 31, 2026
🇺🇸 Goldman Sachs Small Cap Value Insights FundGoldman Sachs Asset Management, L.P.54,970$1 M0.13%0.06%newJul 31, 2026
🇺🇸 U.S. Core Equity 1 PortfolioDimensional Fund Advisors LP54,321$1 M0.13%<0.01%+20%Jul 31, 2026
🇺🇸 State Street SPDR S&P Health Care Equipment ETFSSGA Funds Management, Inc.61,173$1 M0.15%0.53%−34%Jun 30, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC49,233$1 M0.12%0.02%+14%Jul 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC63,002$1 M0.15%<0.01%+5.7%May 31, 2026
🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P.57,598$1 M0.14%0.07%+10%May 31, 2026
🇺🇸 Transamerica Small Cap ValueTransamerica Asset Management, Inc.43,000$1 M0.10%0.56%no changeJul 31, 2026
🇺🇸 Vanguard U.S. Multifactor ETFThe Vanguard Group, Inc.50,141$1 M0.12%0.09%no changeMay 31, 2026
🇺🇸 Royce Capital Fund - Micro-Cap PortfolioRoyce & Associates, LP44,184$1 M0.11%0.41%—Jun 30, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC40,624$1 M0.10%0.01%−1.3%Jun 30, 2026
🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC39,911$1 M0.09%0.02%+10%Jun 30, 2026
🇺🇸 Schwab Small-Cap Equity FundCharles Schwab Investment Management, Inc.34,907$1 M0.08%0.08%newJul 31, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.31,851$0 M0.08%<0.01%no changeJul 31, 2026
🇺🇸 SIMT Tax-Managed Small/Mid Cap FundSEI Institutional Managed Trust34,707$0 M0.08%0.06%−20%Jun 30, 2026
🇺🇸 JPMorgan Small Cap Value PortfolioBrighthouse Investment Advisers, LLC32,983$0 M0.08%0.13%newJun 30, 2026
🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC27,445$0 M0.07%<0.01%no changeJul 31, 2026
🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC35,214$0 M0.08%<0.01%no changeMay 31, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC25,360$0 M0.06%0.02%no changeJun 30, 2026
🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC22,195$0 M0.05%<0.01%+7.7%Jul 31, 2026
🇺🇸 Venerable US Small Cap FundVenerable Investment Advisers, LLC24,203$0 M0.06%0.19%+4.4%Jun 30, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation23,792$0 M0.06%0.01%−14%Jun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.22,891$0 M0.05%<0.01%+88%Jun 30, 2026
🇺🇸 Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors22,762$0 M0.05%0.01%−24%Jun 30, 2026
🇺🇸 U.S. Vector Equity PortfolioDimensional Fund Advisors LP19,026$0 M0.05%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc.23,467$0 M0.06%0.02%+5.1%May 31, 2026
🇺🇸 Schwab U.S. Broad Market ETFCharles Schwab Investment Management, Inc.23,038$0 M0.05%<0.01%no changeMay 31, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC17,796$0 M0.04%0.02%+9.5%Jul 31, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.20,026$0 M0.05%<0.01%−9.4%Jun 30, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC22,290$0 M0.05%<0.01%no changeMay 31, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.19,201$0 M0.05%0.02%+5.0%Jun 30, 2026
🇺🇸 State Street SPDR US Small Cap Low Volatility Index ETFSSGA Funds Management, Inc.19,044$0 M0.05%0.10%newJun 30, 2026
🇺🇸 Vanguard U.S. Multifactor FundThe Vanguard Group, Inc.21,328$0 M0.05%0.09%no changeMay 31, 2026
🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC15,193$0 M0.04%<0.01%+3.2%Jul 31, 2026
🇺🇸 U.S. Sustainability Core 1 PortfolioDimensional Fund Advisors LP14,917$0 M0.04%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.16,851$0 M0.04%<0.01%−20%Jun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company16,083$0 M0.04%0.01%no changeMay 31, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.13,297$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 Bridge Builder Small/Mid Cap Value FundOLIVE STREET INVESTMENT ADVISERS LLC13,079$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC12,435$0 M0.03%0.01%−0.2%Jun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC12,374$0 M0.03%0.01%+62%Jun 30, 2026
🇺🇸 Dimensional US Core Equity Market ETFDimensional Fund Advisors LP10,769$0 M0.03%<0.01%+61%Jul 31, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC10,633$0 M0.03%0.02%−18%Jul 31, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC11,540$0 M0.03%<0.01%−2.5%Jun 30, 2026
🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP9,874$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC10,544$0 M0.03%0.01%no changeJun 30, 2026
🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors10,259$0 M0.02%<0.01%−0.7%Jun 30, 2026
🇺🇸 Clearwater Select Equity FundClearwater Management Co Inc.9,521$0 M0.02%0.02%−44%Jun 30, 2026
🇺🇸 AQR Small Cap Momentum Style FundAQR CAPITAL MANAGEMENT, LLC10,763$0 M0.03%0.07%—Mar 31, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC8,350$0 M0.02%0.05%+24%Jun 30, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC8,259$0 M0.02%0.01%no changeJun 30, 2026
🇺🇸 Vanguard U.S. Quality Factor ETFThe Vanguard Group, Inc.9,180$0 M0.02%0.02%newMay 31, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC8,019$0 M0.02%<0.01%+27%Jun 30, 2026
🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC7,824$0 M0.02%0.02%+13%Jun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS7,690$0 M0.02%0.01%no changeJun 30, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION8,570$0 M0.02%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC6,228$0 M0.01%0.02%−0.1%Jul 31, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC6,128$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.7,675$0 M0.02%<0.01%−5.1%May 31, 2026
🇺🇸 Small Cap Core FundNorthern Trust Investments, Inc.6,406$0 M0.02%0.02%−4.6%Jun 30, 2026
🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP5,298$0 M0.01%<0.01%+61%Jul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at AngioDynamics, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$655 K
3 sales, 2 insiders
Net, 12 months
-$655 K
open market only
Insiders on file
45
since
$240 K-$344 K$0Apr 2024: bought $67 K (1 trades), sold $0 (0 trades)Apr 24Oct 2024: bought $136 K (4 trades), sold $0 (0 trades)OctJan 2025: bought $0 (0 trades), sold $50 K (1 trades)Jan 25Oct 2025: bought $240 K (3 trades), sold $0 (0 trades)OctJul 2026: bought $0 (0 trades), sold $344 K (1 trades)JulOct 2026: bought $0 (0 trades), sold $311 K (2 trades)Oct
Bought (open market)Sold (open market)Hover a month for the totals
AngioDynamics, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Eric HonrothPresident and CEO, DirectorGrant or award+62,928——62,928Form 4
filed Eric HonrothPresident and CEO, DirectorGrant or award+38,265——101,193Form 4
filed Stephen A. TrowbridgeEVP and CFOSell-23,615$12.27$290 K280,461Form 4
filed Stephen A. TrowbridgeEVP and CFOSell-1,720$12.17$21 K304,076Form 4
filed Warren Nighan Jr.SVP Quality and RegulatorySell-23,370$14.72$344 K64,745Form 4
filed Stephen A. TrowbridgeEVP and CFOOption exercise+16,296——314,115Form 4
filed Warren Nighan Jr.SVP Quality and RegulatoryOption exercise+5,694——89,786Form 4
filed Laura PiccininiSVP InternationalOption exercise+8,047——86,435Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: AngioDynamics, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
2.0 M
4.8% of shares · 2.92 days to cover
Buybacks, Q2 2026
$0M
Q4 2026
Shares sold short, last 24 reportsAll stocks →
AngioDynamics, Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q2 2026Q4 2026$0M
Q1 2026Q3 2026$0M
Q4 2025Q2 2026$0M
Q3 2025Q1 2026$0M
Q2 2025Q4 2025$0M
Q1 2025Q3 2025$0M
Q4 2024Q2 2025$1.1M
Q3 2024Q1 2025$0.6M
Q2 2024Q4 2025$0M
Q1 2024Q3 2025$0M
Q4 2023Q2 2025$0M
Q3 2023Q1 2025$0M
Q2 2018Q4 2018$0M
Q1 2018Q3 2018$0M
Q2 2017Q4 2017$5.7M
Q1 2017Q3 2017$0M

Fails to deliver

  • : 8,620 shares at $12.17
  • : 136 shares at $15.47
  • : 992 shares at $15.77
  • : 26 shares at $15.82
  • : 1,363 shares at $15.67

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

AngioDynamics, Inc. scorecard#

Passes 7 of the 21 checks that could be worked out: strongest in financial health (2 of 3), weakest in growth (1 of 6). Fiscal year 2025; market cap of Oct 27, 2026.

  • Valuation2 of 5
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✓Price to book below its peers' median3.0×Price to book 3.0× against Medical Instruments's median of 3.9×.
    • ✓Price to sales below its peers' median1.6×Price to sales 1.6× against Medical Instruments's median of 3.0×.
    • ✗Free cash flow yield above 5%0.1%Free cash flow is 0.1% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth1 of 6
    • ✓Revenue grew in the newest year9.5%Revenue up 9.5% in fiscal 2025.
    • ✗Revenue up more than 5% a year over three years-1.9%-1.9% a year over the three years to fiscal 2025.
    • ✗Faster growth over three years than its peers' median-1.9%-1.9% a year against Medical Instruments's median of 5.0% (37 companies).
    • ✗Earnings per share grew in the newest year-0.88 vs -0.83Diluted EPS -0.88 in fiscal 2025 against -0.83 the year before (report's currency).
    • ✗Net income higher than five years earlier-$37 M-$37 M in fiscal 2025 against -$32 M in 2020.
    • ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2025.
  • Profitability1 of 5
    • ✗Profitable in the newest year-$37 MNet income -$37 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median-12.5%-12.5% against Medical Instruments's median of 7.2% (46 companies).
    • ✗Return on equity above 15%-20.8%-20.8% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier-12.5%-12.5% in fiscal 2025 against -15.1% in 2022.
  • Financial health2 of 3
    • ✓Short-term assets cover short-term liabilities2.2×Current ratio 2.19 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years1 of 3Positive in 1 of the three years to fiscal 2025.
    • ✓Altman Z-score outside the distress zone1.85Z-score 1.85 (grey zone) for fiscal 2025.
  • Shareholder returns1 of 2
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✓Share count up no more than 2% in a year1.6%Diluted shares up 1.6% in fiscal 2025.
    • ✗Dividends and buybacks above 3% of the market value0.0%Dividends and buybacks were 0.0% of the market value.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Medical Instruments, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from AngioDynamics, Inc.'s statements, beside the median of Medical Instruments.

AngioDynamics, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin-12.5%7.2%
Net margin-11.5%3.8%
Return on equity-20.8%3.5%
Revenue growth, 3 years a year-1.9%5.0%
Revenue growth9.5%8.9%
Free cash flow margin0.2%6.3%

4of 8on the Piotroski tests of financial strength

  • Net loss of $37 million, the 7th loss-making year in a row.

AngioDynamics, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

AngioDynamics, Inc.: statements by fiscal year
PeriodTrendFY 2025to May 31, 2026FY 2024to May 31, 2025FY 2023to May 31, 2024FY 2022to May 31, 2023FY 2021to May 31, 2022FY 2020to May 31, 2021FY 2019to May 31, 2020FY 2018to May 31, 2019FY 2017to May 31, 2018FY 2016to May 31, 2017
Income statement
Revenue320292304339316291264271262r270r
Cost of revenue145135149165150134114115118r126r
Gross profit175158155174166157150156144r144r
Research and development292632303136302824r24r
Selling and marketing1131031031049581797773r75r
General and administrative444241403836383531r31r
Operating expenses215198402225194192317165158r155r
Operating income−40−40−192−51−28−35−167−9.4−14r−11r
Interest expense and finance costs——−1.62.70.70.90.95.13.12.8
Other non-operating income (expense)3.94.9−0.8−0.6−0.80.1−0.1r−0.2r−3.1−3.1
Income before tax−36−34−192−54−30−36−168−15−17r−14r
Income tax0.4−0.0−7.3−2.0−3.4−4.5−1.3−3.6−11r−7.2r
Income from continuing operations—————−32−167−11−6.2−7.1
Income from discontinued operations—————00722312
Net income attributable to shareholders−37−34−184r−52r−27−32r−16761165.0
Earnings per share, basic-0.88-0.83-4.59-1.33-0.68-0.82-4.391.640.440.14
Earnings per share, diluted-0.88-0.83-4.59-1.33-0.68-0.82-4.391.640.440.14
Shares, weighted average (basic)42414039393838373737
Shares, weighted average (diluted)424140393938383737r37r
Balance sheet
Cash and cash equivalents545676452948542287448
Short-term investments———————01.31.2
Receivables48434453523531443945
Inventory526261555149604039r55
Other current assets8.87.5134.6118.77.34.04.36.1r
Current assets163168193164143141153315168154
Property, plant and equipment273236444537282426r45
Right-of-use (leased) assets5.13.95.85.17.09.410———
Goodwill——0159201201201348286r361
Other intangible assets676977111152169197145113r146
Total assets267280318533553561594836705708
Accounts payable32333840282019231618
Debt due within a year——————07.55.05.0
Current liabilities75769184745851735772
Long-term debt———————1248791
Lease liabilities (non-current)3.92.13.93.34.77.38.3———
Total liabilities9697112154128122139222163193
Retained earnings−466−429−395−211−158−132−100665.1−11
Shareholders' equity171183206378424439455615543515
Total liabilities and equity267280318533553561594836705708
Shares outstanding42414040393938383737
Cash-flow statement
Depreciation and amortization23262831292624262325
Share-based compensation149.81111118.67.69.27.96.2
Cash from operating activities3.1−10−280.1−7.224−15374156
Capital expenditure−2.6−4.5−2.5−3.8−4.3−5.2−7.2−3.1−2.4−3.0
Cash from investing activities−5.9−10124−9.7−19−14−6383−3.7−2.6
Debt issued———————00116
Debt repaid00−50−450−20−133−15−5.0−140
Shares bought back0−1.700———00−14
Cash from financing activities0.6−0.3−64257.7−17−9534−12−38
Exchange-rate effect on cash0.30.40.10.0−0.50.3−0.1−0.40.50
Change in cash−2.0−203116−19−6.3−1731542715
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Aug 31, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What AngioDynamics, Inc. sells: revenue by product line, fiscal 2026#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2025. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Med Device$170 M53%
  • Med Tech$150 M47%

Business segments

  • Med Device$170 M53%
  • Med Tech$150 M47%

Countries and regions

Source: SEC annual report (XBRL data) · as of May 31, 2026

Where AngioDynamics, Inc. operates: 8 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 8 subsidiaries on file.

AngioDynamics, Inc.: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters1 office1 subsidiary$275 M86%
🇧🇷 Brazil1 subsidiary—
🇨🇦 Canada1 subsidiary—
🇫🇷 France1 subsidiary—
🇮🇱 Israel1 subsidiary—
🇮🇹 Italy1 subsidiary—
🇳🇱 Netherlands1 subsidiary—
🇬🇧 UK1 subsidiary—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Executive pay at AngioDynamics, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2026
$6.1 M
Mr. Clemmer
Other top executives, average
$1.8 M
the CEO earned 3.4× this
$100 invested is now
$50
peer group: $57
AngioDynamics, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2026Mr. Clemmer$6.1 M$13.7 M$1.8 M$50 (peers $57)
2025Mr. Clemmer$5.5 M$6.8 M$1.5 M$44 (peers $43)
2024Mr. Clemmer$5.0 M$971 K$1.3 M$27 (peers $43)
2023Mr. Clemmer$4.0 M−$2.1 M$914 K$41 (peers $56)
2022Mr. Clemmer$5.7 M$5.0 M$1.3 M$85 (peers $59)
2021Mr. Clemmer$4.0 M$13.9 M$1.0 M$226 (peers $124)

Source: SEC proxy statement (Form DEF 14A) · as of May 31, 2026

Events at AngioDynamics, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Directors and officers 4 · Material agreement 3 · New debt 1 · Shareholder vote 2 · Results announced 12

AngioDynamics, Inc.: events reported to the SEC
FiledWhat happenedFiling
Directors and officersMaterial agreement8-K
Results announced8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Results announced8-K
Material agreementNew debt8-K
Results announced8-K
Results announced8-K
Directors and officersShareholder vote8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Material agreement8-K
Directors and officers8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Oct 8, 2026

H-1B hiring at AngioDynamics, Inc.#

2 labor condition applications certified in fiscal 2023 for 2 positions, at a median wage of $85 K a year.

Certified, FY2023
2
#1,580 among companies on value.today
Worker positions
2
Median wage offered
$85 K
a year, full-time
Applications filed
3
AngioDynamics, Inc.: most frequent H-1B job titles in fiscal 2023
Job titlePositionsMedian wage offered
Clinical Affairs SpecialistCompliance Officers1$86 K
Regulatory Affairs Specialist IICompliance Officers1$85 K

Where: Marlborough, MA 2

AngioDynamics, Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202322$85 K3
FY202211$113 K1
FY202055$80 K6

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as ANGIODYNAMICS, INC.

Discuss AngioDynamics, Inc.#

3 automatic updates and 0 member comments. Sign in to comment and react.

  • Insider trading in October 2026automatic update · Oct 31, 2026

    Directors and officers of AngioDynamics, Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 1 insider sold shares worth about $310,688 in 2 trades. Awards, option exercises and shares withheld for tax are not counted.

  • Results announced on 8 October 2026automatic update · Oct 8, 2026

    AngioDynamics, Inc. announced results on 8 October 2026 (SEC Form 8-K, item 2.02). For the quarter ended 31 August 2026: revenue of $81 million (up 7% from a year earlier) and a net loss of $7 million.

  • Mutual funds: 158 funds hold $148 millionautomatic update · Jul 31, 2026

    158 mutual funds in 2 countries hold shares of AngioDynamics, Inc. worth $148 million, about 26.7% of the company (funds' newest reports, up to 31 July 2026). Since their previous reports 66 funds added shares and 43 sold; on balance they bought $4 million. Share splits are not counted as trading.

How AngioDynamics, Inc. compares in Medical Instruments

  • Market cap$512 M · higher than 30% of 116
  • Revenue$320 M · higher than 40% of 120
  • Net margin-10.1% · higher than 13% of 114
  • Revenue growth9.5% · higher than 54% of 49
  • Price / sales1.6× · lower than 85% of 85
  • Price / book3.0× · lower than 55% of 84
  • FCF yield0.1% · higher than 42% of 39

Peer comparison · Medical Instruments

CompanyMarket capP/ENet marginRev. growth
AngioDynamics, Inc.🇺🇸$512 M—-10.1%+9.5%
Intuitive Surgical, Inc.🇺🇸$155.6 B52.6×25.5%+20.5%
EssilorLuxottica S.A.🇫🇷$88.0 B32.1×8.1%+4.5%
HOYA Corporation🇯🇵$56.2 B32.8×25.4%—
Becton, Dickinson and Company🇺🇸$54.0 B57.4×4.2%+8.2%
Alcon Inc.🇨🇭$37.1 B37.9×9.4%+4.9%
ResMed Inc.🇺🇸$35.3 B22.1×27.8%+9.8%
West Pharmaceutical Services, Inc.🇺🇸$27.1 B42.4×18.8%+6.3%
Terumo Corporation🇯🇵$24.9 B27.0×12.0%—

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 27, 2026
Annual results:
For year ending May-2026
Balance sheet:
As of May-2026
Employees:
As on 2021
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, GLEIF register; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at AngioDynamics, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show AngioDynamics, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about AngioDynamics, Inc.? Suggest a correction